from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1341/-

LFCtreatmentdescriptionclass of inhibitor

-0.280

Amikacinug/mL Amikacintranslation

0.967

Cap5-10ug/mL Capreomycintranslation

0.748

Rox10-50 ug/mL Roxithromycintranslation

-0.398

SM2-5 ug/mL Streptomycintranslation

-0.730

Tet5-10 ug/mL Tetracyclinetranslation

0.756

Rif0.2-5ug/mL Rifampicintranscription

-0.314

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.841

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.301

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.301

CPZ10-50 ug/mL Chlorpromazinerespiration

1.460

Clofazimine10-13 ug/mL Clofaziminerespiration

0.561

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.769

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.898

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.997

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.596

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.147

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.080

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.180

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.053

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.684

KCN5-20 ug/mL Potassium cyaniderespiration

0.446

NaN30.2-2 mM Sodium aziderespiration

-1.836

Nigericin50 uM Nigericinrespiration

-0.536

TRC10-150 ug/mL Triclosanrespiration

1.297

TRZ10-25 ug/mL Thioridazinerespiration

-1.717

Valinomycin0.5-10 uM Valinomycinrespiration

-0.888

ZnSO42 mM ZnSO4respiration

-0.259

menadione6-10 ug/mL Menadionerespiration

0.276

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.459

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.388

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.638

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.147

NRP_1Non-replicating persistence stage 1dosRassociated

-0.982

Amp0.2mg/mL AmpicillincellWall

0.102

Cephalexin20-100 ug/mL CephalexincellWall

0.157

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.613

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.308

EMB10-20 ug/mL EthambutolcellWall

0.098

Eta12-40 ug/mL EthionamidecellWall

1.191

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.208

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.475

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.104

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.368

BZA0.12 mg/mL BenzamidearomaticAmides

-0.989

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.699

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.483

H2O24 mM hydrogen peroxideDNAdamaging

-0.404

Levo10 ug/mL LevofloxacinDNAdamaging

0.238

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.509

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.524

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.046

UVUV-irradiationDNAdamaging

2.342

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.368

Antimycin12.5-50 ug/mL Antimycin A?

0.122

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.467

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.044

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.687

PA8240.2-2 ug/mL PA-824?

1.510

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.035

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.605

Verapamil50 uM Verapamil?

-0.237

mercaptoethanol2 mM 2-Mercaptoethanol?

0.134

methoxatin10-20 ug/mL Methoxatin?